This section offers a closer look to TransQST activities through interviews to project partners. These interviews also have the aim to provide deeper insights into the application and applicability of the project results, while introducing the members of the teams working behind the scenes.
How has GSK been involved in the TransQST project? We have actively contributed to each of the organ toxicity work packages (WP5-liver, WP6-kidney, WP7-heart and WP8-gastrointestinal system). Our contribution has included providing legacy datasets, data analysis, modelling, and the generation of novel data (using established and novel technologies) where the need has been identified. All […]Read moreMore Tag
What is ORION’s main focus? Orion Corporation Orion Pharma is a globally operating Finnish pharmaceutical company. The core therapy areas of Orion’s pharmaceutical R&D are currently pain and oncology. When entering the first clinical trials with new molecular entities it is extremely important that we have applied the best state-of-the-art technologies for assessing the safety […]Read moreMore Tag
What is the main focus of your group? At the Institute for Computational Biomedicine, we develop and apply computational methods to analyse complex biomedical data. Our goal is to acquire a functional understanding of molecular mechanisms in health and disease. We apply these insights to improve diagnosis and to develop novel therapeutics that we apply […]Read moreMore Tag
Contributors: Panuwat Trairatphisan Diana Clausznitzer What are your main research interests? In the Quantitative Translational Systems Pharmacology and Toxicology group, we aim to apply quantitative modeling and simulation methods to support the development of new medications and treatment modalities to improve patients’ lives. PK/PD modeling for drug pharmacokinetics and efficacy is routinely and successfully integrated […]Read moreMore Tag
What is IMIM’s main focus? Our research group Integrative Biomedical Informatics, which belongs to IMIM (Institut Hospital del Mar d’Investigacions Mèdiques) and UPF (University of Pompeu Fabra) located in Barcelona, Spain, is focused on developing bioinformatic tools to gain insight from biomedical data for improving human health. We use data mining and integration and natural […]Read moreMore Tag